The Single Best Strategy To Use For MCU-i11
Pharmacological inhibition of the ataxia telangiectasia and Rad3-relevant protein serine/threonine kinase (ATR; often known as FRAP-connected protein (FRP1)) has emerged as being a promising strategy for cancer treatment that exploits synthetic lethal interactions with proteins involved with DNA hurt repair, overcomes resistance to other therapies